Robert Roscigno is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Dec 2011 and Oct 2013: Vero Biotech Inc. (Atlanta, GA — pharmaceuticals — 2011–2013; $29.9M reported sold to 41 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David Fine (3 shared filings), Kurt Dasse (3 shared filings), Steven Shulman (3 shared filings), Anthony S. Loumidis (2 shared filings), Theo Melas-Kyriazi (2 shared filings) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Robert Roscigno and found 7 differences, 1 worth asking the sponsor about: Form D filed 315 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.